Ascendis Pharma A/s · NASDAQ:ASND
Bienaime Jean Jacques bought 500 Ascendis Pharma A/s shares (Form 4)
Traded May 29, 2026 · Filed Jun 1, 2026
On May 29, 2026, Bienaime Jean Jacques (Director) bought 500 Ascendis Pharma A/s shares at an average US$223.12 for US$112K, leaving 900 shares. Filed Jun 1, 2026 (Form 4).
- Bought
- 500 shares
- Price
- US$223.12 average (US$222.30 to US$223.76)
- Value
- US$112K
- Holding after
- 900 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Ordinary Shares | Buy | 200 | US$223.76 | 600 | Direct |
| May 29, 2026 | Ordinary Shares | Buy | 200 | US$222.30 | 800 | Direct |
| May 29, 2026 | Ordinary Shares | Buy | 100 | US$223.50 | 900 | Direct |
Source
Related
- Ascendis Pharma A/s
- Bienaime Jean Jacques
- Ascendis Pharma A/s shareholders
- Form 4 · Bienaime Jean Jacques · Aug 18, 2026
- Form 4 · Bienaime Jean Jacques · May 27, 2026
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Smith Scott Thomas · Jun 1, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026